Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference
28 11월 2023 - 6:15AM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
management will participate in a fireside chat at the 6th Annual
Evercore ISI HealthCONx Conference on Tuesday, November 28th at
5:05 pm ET. A webcast of the presentation will be available on the
"Events & Presentations" page of the "Investors & Media"
section of the Celldex website. A replay will be available for 90
days following the event.
About Celldex Therapeutics, Inc.Celldex is a
clinical stage biotechnology company leading the science at the
intersection of mast cell biology and the development of
transformative therapeutics for patients. Our pipeline includes
antibody-based therapeutics which have the ability to engage the
human immune system and/or directly affect critical pathways to
improve the lives of patients with severe inflammatory, allergic
and autoimmune and other devastating diseases. Visit
www.celldex.com
Company ContactSarah CavanaughSenior Vice
President, Corporate Affairs & Administration(508)
864-8337scavanaugh@celldex.com
Patrick TillMeru Advisors(484)
788-8560ptill@meruadvisors.com
Celldex Therapeutics (NASDAQ:CLDX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Celldex Therapeutics (NASDAQ:CLDX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
